The Texas Racing Commission has authorized the Texas Medical Diagnostic Laboratory to increase the amount of ELISA tests it conducts and decrease the number of screens it evaluates from urine samples collected for post-race analysis.
The Kentucky Equine Drug Research Council met Thursday at Keeneland to discuss options to identify and enforce the prohibited use of erythropoietin (EPO).
The attached list of racing organizations and officials were invited to attend a one-day workshop for the purpose of determining if agreement could be reached as to the need for a uniform policy for racehorse medication in the United States, and if so, where agreement can be reached on elements of such a policy. The workshop consisted of two segments: a two-hour open session briefing by experts on topics pertinent to the purpose of the Summit, and an intensive seven-hour workshop for the invited representatives which was conducted by a professional facilitator from outside the racing industry.
Most Popular Stories
- China Horse Club Buys into California Chrome
- Nobiz Like Shobiz Settling in at Old Friends
- Stellar Wind Works in Company for Distaff
- Frosted Confirmed for Breeders' Cup Classic
- Report: Dips in Stallion, Mares-Bred Numbers
- Quidura Reigns for Motion in Valley View
- Beholder Blazes in Breeders' Cup Drill
- 'Stubborn' Runhappy Works a Mile at Keeneland
- Mr. Nightlinger Moved to Mighty Acres
- Court Rules Borells Have No Claim on Horses